CIK: 0002054419
Total reported value
$151.0M
Reporting period: 2026-03-31 · Number of holdings: 2
Alta Partners Management Company, L.P. disclosed 2 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $151.0M and a quarterly turnover rate of 37.3%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "A"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Trim TYRA
0.0% $45.9M
Add VIR
0.0% $1.5M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TYRA | Tyra Biosciences INC | Stock-Other | 96.97% | -0.06% | — | |
| 2 | VIR | Vir Biotechnology INC | Stock-Other | 3.03% | +0.06% | — |
Performance for Q3 2026
-7.5%
Performance Last 4 Quarters
+188.1%
Not enough sector-mapped data yet
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | VIR | Vir Biotechnology INC | +0.1% | — | Unchanged |
| 2 | TYRA | Tyra Biosciences INC | -0.1% | — | Unchanged |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-04-21 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-01-13 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-07 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-14 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-12 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-05 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0002044285
Total reported value
$151.0M
69 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001989379
Total reported value
$151.0M
123 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0002040317
Total reported value
$151.1M
399 stks
2026-03-31
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0001131399
Total reported value
$599.2M
13 stks
2026-03-31
1 of the top 5 holdings overlap, including Vir Biotechnology INC
CIK 0001274403
Total reported value
$677.1M
10 stks
2026-03-31
1 of the top 5 holdings overlap, including Vir Biotechnology INC
CIK 0001316915
Total reported value
$20.0M
65 stks
2023-03-31
Stale — no recent filing
1 of the top 5 holdings overlap, including Vir Biotechnology INC